We have not observed evidence of immunosuppressive effects of our IFN gene therapy, as shown by efficient clearance of viral infection in long-term transplanted mice13 and protection from serial tumor challenges (this work), possibly because of the low-level sustained IFN expression induced in the target tissues. This evidence concerns the gene IFNA1 and neoplasm.